Cingulate (CING) to Release Earnings on Monday

Cingulate (NASDAQ:CING) is expected to be releasing its earnings data before the market opens on Monday, March 24th. Analysts expect Cingulate to post earnings of ($1.48) per share for the quarter.

Cingulate Price Performance

Shares of CING stock opened at $3.96 on Friday. Cingulate has a 12-month low of $1.80 and a 12-month high of $20.83. The firm has a 50-day moving average price of $4.34 and a 200 day moving average price of $4.55.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CING. Roth Mkm assumed coverage on shares of Cingulate in a report on Friday, January 10th. They set a “buy” rating and a $12.00 price target for the company. HC Wainwright reaffirmed a “buy” rating and issued a $20.00 target price on shares of Cingulate in a research note on Thursday, March 6th. Finally, Roth Capital raised shares of Cingulate to a “strong-buy” rating in a research note on Friday, January 10th.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.